Clay Siegall Ph. D. is the co-founder of a leading company based in Seattle called Seattle Genetics. The company is dedicated to medical research, and it is a developer of medication and other patents. The primary focus of the research that is conducted at Seattle Genetics falls in the fight against cancer.
Dr Clay Siegall finished his higher education at George Washington University. From the renowned academic institution, Dr Clay Siegall received his PH. D. in Genetics. After he had graduated from university, Clay Siegall Ph. D. worked at the Bristol-Myers Squibb Pharmaceutical Research Institute for about six years. After that, he was a part of the National Cancer Institute for a few years. Over the course of s successful career, Dr Clay Siegall has been an author for almost a hundred publications that encompass a number of scientific and medical topics. He is also the owner of a drug patent that is available in seventy countries. He also owns 15 other patents.
Seattle Genetics was established as a medical research company in 1998. Clay Siegall Ph. D. serves as the President of the company as well as the chief executive officer and chairman of the board. The reason that Dr Clay Siegall had for founding Seattle Genetics lies in his teenage and young adult life. When Dr Clay Siegall was at the age of 19, his father was diagnosed with cancer. Having to watch his father suffering from the disease made strongly aware of how little doctors could do to help his father and millions of other people from all over the world. When Dr Clay Siegall was at the age of 24, his father passed away from the disease. That made Dr Clay Siegall study genetics at the George Washington University and later worked in Seattle as a researcher.
During the time he spent at the Bristol-Myers Squibb Pharmaceutical Research Institute, Clay Siegall Ph. D. learned how to run and handle a company. He co-founded Seattle Genetics in order to provide oncologists with the tools needed to save the life of their patients. Although the fight against cancer is a long and arduous one, scientists such a Dr Clay Siegall are not giving up.